Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Genes Dev
1997 Dec 01;1123:3157-67. doi: 10.1101/gad.11.23.3157.
Show Gene links
Show Anatomy links
Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F
,
Pouponnot C
,
Massagué J
.
???displayArticle.abstract???
Upon ligand binding, the receptors of the TGFbeta family phosphorylate Smad proteins, which then move into the nucleus where they activate transcription. To carry out this function, the receptor-activated Smads 1 and 2 require association with the product of deleted in pancreatic carcinoma, locus 4 (DPC4), Smad4. We investigated the step at which Smad4 is required for transcriptional activation. Smad4 is not required for nuclear translocation of Smads 1 or 2, or for association of Smad2 with a DNA binding partner, the winged helix protein FAST-1. Receptor-activated Smad2 takes Smad4 into the nucleus where they form a complex with FAST-1 that requires these three components to activate transcription. Smad4 contributes two functions: Through its amino-terminal domain, Smad4 promotes binding of the Smad2/Smad4/FAST-1 complex to DNA; through its carboxy-terminal domain, Smad4 provides an activation function required for Smad1 or Smad2 to stimulate transcription. The dual function of Smad4 in transcriptional activation underscores its central role in TGFbeta signaling.
???displayArticle.pubmedLink???
9389648
???displayArticle.pmcLink???PMC316747 ???displayArticle.link???Genes Dev
Baker,
A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway.
1996, Pubmed,
Xenbase
Baker,
A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway.
1996,
Pubmed
,
Xenbase
Barrett,
Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma.
1996,
Pubmed
Chen,
A transcriptional partner for MAD proteins in TGF-beta signalling.
1996,
Pubmed
,
Xenbase
Chen,
Smad4 and FAST-1 in the assembly of activin-responsive factor.
1997,
Pubmed
,
Xenbase
Cárcamo,
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
1994,
Pubmed
Datto,
Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter.
1995,
Pubmed
Derynck,
Intracellular signalling: the mad way to do it.
1996,
Pubmed
Eppert,
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.
1996,
Pubmed
,
Xenbase
Goyette,
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.
1992,
Pubmed
Graff,
Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.
1996,
Pubmed
,
Xenbase
Hahn,
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
1996,
Pubmed
Hannon,
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
1994,
Pubmed
Hata,
Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.
1997,
Pubmed
,
Xenbase
Hayashi,
The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling.
1997,
Pubmed
Hoodless,
MADR1, a MAD-related protein that functions in BMP2 signaling pathways.
1996,
Pubmed
Huang,
Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo.
1995,
Pubmed
,
Xenbase
Iavarone,
Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
1997,
Pubmed
Inagaki,
Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site.
1994,
Pubmed
Keeton,
Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.
1991,
Pubmed
Kerr,
Transforming growth factor beta 1 and cAMP inhibit transcription of epidermal growth factor- and oncogene-induced transin RNA.
1988,
Pubmed
Kim,
Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic.
1997,
Pubmed
Kim,
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma.
1996,
Pubmed
Kretzschmar,
Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1.
1997,
Pubmed
Kretzschmar,
The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.
1997,
Pubmed
Lagna,
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
1996,
Pubmed
,
Xenbase
Lechleider,
Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1.
1996,
Pubmed
Lillie,
Transcription activation by the adenovirus E1a protein.
1989,
Pubmed
Liu,
A human Mad protein acting as a BMP-regulated transcriptional activator.
1996,
Pubmed
,
Xenbase
Macías-Silva,
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.
1996,
Pubmed
Massaous,
TGF-beta signalling through the Smad pathway.
1997,
Pubmed
Nagatake,
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
1996,
Pubmed
Nakao,
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
1997,
Pubmed
,
Xenbase
Nakao,
Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway.
1997,
Pubmed
,
Xenbase
Newfeld,
Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGF-beta responsive cells.
1996,
Pubmed
,
Xenbase
Pietenpol,
TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.
1990,
Pubmed
Reynisdóttir,
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
1995,
Pubmed
Riggins,
Mad-related genes in the human.
1996,
Pubmed
Rossi,
A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.
1988,
Pubmed
Sadowski,
A vector for expressing GAL4(1-147) fusions in mammalian cells.
1989,
Pubmed
Savage,
Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components.
1996,
Pubmed
Schutte,
DPC4 gene in various tumor types.
1996,
Pubmed
Sekelsky,
Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.
1995,
Pubmed
Shi,
A structural basis for mutational inactivation of the tumour suppressor Smad4.
1997,
Pubmed
Thomsen,
Xenopus mothers against decapentaplegic is an embryonic ventralizing agent that acts downstream of the BMP-2/4 receptor.
1996,
Pubmed
,
Xenbase
Topper,
Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium.
1997,
Pubmed
Turner,
Expression of achaete-scute homolog 3 in Xenopus embryos converts ectodermal cells to a neural fate.
1994,
Pubmed
,
Xenbase
Uchida,
Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers.
1996,
Pubmed
Watanabe,
Cloning and characterization of a novel member of the human Mad gene family (MADH6).
1997,
Pubmed
Weis-Garcia,
Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling.
1996,
Pubmed
Wiersdorff,
Mad acts downstream of Dpp receptors, revealing a differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye.
1996,
Pubmed
Wieser,
GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.
1995,
Pubmed
Wrana,
MAD-related proteins in TGF-beta signalling.
1996,
Pubmed
,
Xenbase
Wrana,
Mechanism of activation of the TGF-beta receptor.
1994,
Pubmed
Wu,
Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4.
1997,
Pubmed
Yingling,
Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth.
1996,
Pubmed
Zentella,
Transforming growth factor beta induces myoblast differentiation in the presence of mitogens.
1992,
Pubmed
Zhang,
The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
1997,
Pubmed
,
Xenbase
Zhang,
Receptor-associated Mad homologues synergize as effectors of the TGF-beta response.
1996,
Pubmed
de Caestecker,
Characterization of functional domains within Smad4/DPC4.
1997,
Pubmed
